Successful control of bleeding during supracondylar amputation caused by severe compartment syndrome in patient with haemophilia A and high titre of inhibitor

Haemophilia

Volumn 15, Issue 2, 2009, Pages 601-602

  Rajic, Nebojsa ^a   Savic, A ^a   Popovic, S ^a   Urosevic, I ^a   Savic, I ^a  

^a Clinical Centre of Vojvodina   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; CALCIFICATION; CASE REPORT; CLINICAL FEATURE; COMPARTMENT SYNDROME; ECHOGRAPHY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HEMOPHILIA A; HOSPITAL ADMISSION; HUMAN; INTRAOPERATIVE HEMORRHAGE; JOINT MALFORMATION; JOINT MOBILITY; JOINT RADIOGRAPHY; KNEE; LEG PAIN; LIMB AMPUTATION; OSTEOPENIA; PAIN THRESHOLD; PEROPERATIVE COMPLICATION; PHLEGMON; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; WOUND CARE;

AMPUTATION; BLOOD COAGULATION FACTOR INHIBITORS; COMPARTMENT SYNDROMES; FACTOR VIII; HEMOPHILIA A; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 63349086898     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01943.x     Document Type: Article

References (5)

1. Hay RMC, Brown S, Collins PW et al. The diagnosis and management of factor VIII and IX inhibitors: A guideline from the United Kingdom Haemophilia centre Doctors Organisation. Br J Haematol 2006; 133: 591-605.
2. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: A review of the literature. Haemophilia 2008; 14: 233-41.
3. Ludlam CA, Smith MP, Morfini M et al. A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: A pharmacokinetic and efficacy evaluation. Br J Haematol 2003; 120: 808-13.
4. Kraut EH, Aledort LM, Arkin S et al. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: An experiential retrospective chart review. Haemophilia 2007; 13: 508-17.
5. Hayashi T, Tanaka I, Shima M et al. Unresponsivenes to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 2004; 10: 397-400.